Answers are grounded in this paper and cite their sources.
Made visible: In situ visualization of the RBL receptor on cancer cell line surfaces was developed by using biotinylated rhamnose and chacotriose bound to quantum dots. The RBL receptor showed different expression patterns on various cell lines. Also, solasodine rhamnosides were found to kill cancer cells more effectively (see graphic). The finding of the RBL receptor-mediated anticancer activity could help the design of chemotherapy agents. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: